Growth Metrics

Corcept Therapeutics (CORT) Other Gross PP&E Adjustments (2016 - 2025)

Corcept Therapeutics' Other Gross PP&E Adjustments history spans 10 years, with the latest figure at -$32.4 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments fell 5.9% year-over-year to -$32.4 million; the TTM value through Dec 2025 reached -$32.4 million, down 5.9%, while the annual FY2025 figure was -$32.4 million, 5.9% down from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was -$32.4 million at Corcept Therapeutics, down from -$5.8 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $3.7 million in Q2 2023 and bottomed at -$32.4 million in Q4 2025.
  • The 5-year median for Other Gross PP&E Adjustments is -$1.3 million (2023), against an average of -$4.8 million.
  • The largest annual shift saw Other Gross PP&E Adjustments soared 806.42% in 2021 before it crashed 1119.39% in 2024.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at -$14.4 million in 2021, then surged by 106.46% to $932000.0 in 2022, then tumbled by 369.42% to -$2.5 million in 2023, then plummeted by 1119.39% to -$30.6 million in 2024, then fell by 5.9% to -$32.4 million in 2025.
  • Per Business Quant, the three most recent readings for CORT's Other Gross PP&E Adjustments are -$32.4 million (Q4 2025), -$5.8 million (Q3 2025), and -$5.3 million (Q2 2025).